Companion Diagnostics Alliances Mount - Clarient and GSK Deal Visited

Companion Diagnostics Alliances Mount - Clarient and GSK Deal Visited

In yet another sign that the ranks of recruitment are expanding in personalized medicine’s fight against cancer, GE Healthcare announced an agreement between its subsidiary Clarient Diagnostic Services and pharmaceutical giant GlaxoSmithKline (GSK). With GE Healthcare, the two entities will form a multi-purpose, data analytics- and companion diagnostics-driven network of laboratories. While operational details of the newly reached agreement have yet to be provided, certain parameters of the prog...


Top Five IVD Segments in the United States - Leaders in Forecast Growth

Top Five IVD Segments in the United States - Leaders in Forecast Growth

( This post represents the second installment of a weekly preview of Kalorama Information’s upcoming publication - The US Market for In Vitro Diagnostic Tests - for March 2014. The posts review the projected top-performing IVD segments in the U.S. market through 2018. )

The United States is the most mature and diversified IVD market in the world, with many clinical tests first developed and approved in the country and most core testing segments already at market saturation. Established market ...